[A mannitol solution as an oral contrast medium in pelvic MRT]. / Eine Mannitollösung als orales Kontrastmittel in der pelvinen MRT.
Rofo
; 163(1): 60-6, 1995 Jul.
Article
em De
| MEDLINE
| ID: mdl-7626755
ABSTRACT
PURPOSE:
Improvement of pelvic MRI using peroral administration of an aqueous mannitol solution.METHODS:
We retrospectively evaluated magnetic resonance examinations of 72 patients with suspected or proven pelvic abnormalities In 36 patients, no bowel marking was carried out. In further 36 patients, we performed a contrast enhancement of the bowel by oral application of 1000 ml of an aqueous mannitol solution.RESULTS:
8/36 (22%) patients suffered from diarrhoea, nausea or meteorism as a result of mannitol application. In group 2, an excellent bowel marking of the small intestine could be obtained in 36/36 (100%) patients. Contrast enhancement of the bowel significantly improved delineation between intestinal structures and pelvic organs or pathologic lesions, respectively. In summary, bowel marking was desirable in 25/36 (69%) of group 1 and helpful in 26/36 (72%) of group 2.CONCLUSION:
Aqueous mannitol solution is a safe bowel contrast agent and improves the diagnostic value of pelvic MRI, but in some cases delineation between marked bowel and cystic pelvic lesions may be uncertain.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Pelve
/
Imageamento por Ressonância Magnética
/
Meios de Contraste
/
Manitol
Idioma:
De
Ano de publicação:
1995
Tipo de documento:
Article